AIBullishFortune Crypto · 5h ago7/10
🧠
Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal targeting neuroimmune therapies
Insilico Medicine and SK Biopharmaceuticals announced a $2.5B partnership focused on AI-driven drug discovery for neuroimmune therapies, representing a major validation of artificial intelligence applications in pharmaceutical development. The deal underscores growing industry confidence in AI's ability to accelerate drug discovery timelines and reduce development costs.
